Literature DB >> 7743593

Behavioural aspects of travellers in their use of malaria presumptive treatment.

P Schlagenhauf1, R Steffen, A Tschopp, P Van Damme, M L Mittelholzer, H Leuenberger, C Reinke.   

Abstract

The use of stand-by treatment for malaria by travellers depends on their knowledge, attitudes and behaviour. We examined the behavioural aspects of a cohort of travellers from Switzerland to low-risk malarial areas who, on recruitment, were provided with a kit containing medication for stand-by treatment, guidelines on the diagnosis of malaria, and materials for collection of blood samples for later confirmation of malaria. All subjects were urged to seek medical advice at the first signs of possible malarial symptoms. Illness (fever as the main indicator) was reported by 123 of the 1187 participants, often accompanied by shivering/chills (36.6%), headache (35.0%), gastrointestinal symptoms (69.9%), and myalgia and/or arthralgia (41.5%). Two-thirds of those ill failed to seek medical attention despite their symptoms and pretravel advice. Only 9 (7.3%) were actually beyond the reach of medical attention. The stand-by treatment was self-administered by 6 travellers, only one of whom had confirmed malaria. Two non-serious adverse events were reported. All users consulted a physician after administering the presumptive treatment. This stand-by approach is limited by inappropriate behaviour and poor malaria awareness among travellers. These negative factors can be mitigated by development of an improved kit containing a simple test for self-diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743593      PMCID: PMC2486760     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

1.  Second form in a segment of the merozoite surface protein 1 gene of Plasmodium vivax among isolates from Rondônia (Brazil).

Authors:  M Porto; M U Ferreira; L M Camargo; S Premawansa; H A del Portillo
Journal:  Mol Biochem Parasitol       Date:  1992-08       Impact factor: 1.759

2.  Simplified preparation of malarial blood samples for polymerase chain reaction.

Authors:  D C Warhurst; F M Awad el Kariem; M A Miles
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

3.  Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-05-26       Impact factor: 17.586

4.  Cardiac effects of antimalarial treatment with halofantrine.

Authors:  F Nosten; F O ter Kuile; C Luxemburger; C Woodrow; D E Kyle; T Chongsuphajaisiddhi; N J White
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

Review 5.  Stand-by treatment of malaria in travellers: a review.

Authors:  P Schlagenhauf; R Steffen
Journal:  J Trop Med Hyg       Date:  1994-06

6.  The rapid manual ParaSight-F test. A new diagnostic tool for Plasmodium falciparum infection.

Authors:  C J Shiff; Z Premji; J N Minjas
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Nov-Dec       Impact factor: 2.184

7.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

Authors:  R Steffen; E Fuchs; J Schildknecht; U Naef; M Funk; P Schlagenhauf; P Phillips-Howard; C Nevill; D Stürchler
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

8.  Long-term malaria prophylaxis with weekly mefloquine.

Authors:  H O Lobel; M Miani; T Eng; K W Bernard; A W Hightower; C C Campbell
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

9.  Travellers' malaria.

Authors:  R Steffen; R H Behrens
Journal:  Parasitol Today       Date:  1992-02

10.  Malaria in Britain: 1977-86.

Authors:  P A Phillips-Howard; D J Bradley; M Blaze; M Hurn
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-23
View more
  9 in total

1.  From Livingstone to ecotourism. What's new in travel medicine?

Authors:  S Houston
Journal:  Can Fam Physician       Date:  2000-01       Impact factor: 3.275

2.  The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?

Authors:  Ron H Behrens; Bernadette Carroll; Urban Hellgren; Leo G Visser; Heli Siikamäki; Lasse S Vestergaard; Guido Calleri; Thomas Jänisch; Bjørn Myrvang; Joaquim Gascon; Christoph Hatz
Journal:  Malar J       Date:  2010-10-04       Impact factor: 2.979

Review 3.  Preventing malaria in travellers.

Authors:  David G Lalloo; David R Hill
Journal:  BMJ       Date:  2008-06-14

Review 4.  Modern malaria chemoprophylaxis.

Authors:  G Dennis Shanks; Michael D Edstein
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study.

Authors:  Christof D Vinnemeier; Camilla Rothe; Benno Kreuels; Marylyn M Addo; Sabine Vygen-Bonnet; Jakob P Cramer; Thierry Rolling
Journal:  Malar J       Date:  2017-01-25       Impact factor: 2.979

6.  Self-diagnosis of malaria by travellers: a cohort study on the use of malaria rapid diagnostic tests provided by a Swiss travel clinic.

Authors:  Delphine Berthod; Jacynthe Rochat; Rachel Voumard; Laurence Rochat; Blaise Genton; Valérie D'Acremont
Journal:  Malar J       Date:  2017-10-28       Impact factor: 2.979

7.  Summary of recommendations on malaria issues in special hosts.

Authors:  A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy
Journal:  Can Commun Dis Rep       Date:  2014-05-15

8.  Summary of recommendations for the diagnosis and treatment of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy
Journal:  Can Commun Dis Rep       Date:  2014-04-03

9.  Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study.

Authors:  Pietro Ferrara; Cristina Masuet-Aumatell; Fernando Agüero; Josep Maria Ramon-Torrell
Journal:  Malar J       Date:  2018-04-02       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.